Literature DB >> 17433846

Brave new (strept)avidins in biotechnology.

Olli H Laitinen1, Henri R Nordlund, Vesa P Hytönen, Markku S Kulomaa.   

Abstract

Avidin and streptavidin are widely used in (strept)avidin-biotin technology, which is based on their tight biotin-binding capability. These techniques are exceptionally diverse, ranging from simple purification and labeling methods to sophisticated drug pre-targeting and nanostructure-building approaches. Improvements in protein engineering have provided new possibilities to develop tailored protein tools. The (strept)avidin scaffold has been engineered to extend the existing range of applications and to develop new ones. Modifications to (strept)avidins--such as simple amino acid substitutions to reduce biotin binding and alter physico-chemical characters--have recently developed into more sophisticated changes, including chimeric (strept)avidins, topology rearrangements and stitching of non-natural amino acids into the active sites. In this review, we highlight the current status in genetically engineered (strept)avidins and illustrate their versatility as advanced tools in the multiple fields of modern bioscience, medicine and nanotechnology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17433846     DOI: 10.1016/j.tibtech.2007.04.001

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  45 in total

1.  Challenging semi-bootstrapping molecular-replacement strategy reveals intriguing crystal packing of rhizavidin.

Authors:  Amit Meir; Oded Livnah
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-03-26

2.  Internalization of biotinylated compounds into cancer cells is promoted by a molecular Trojan horse based upon core streptavidin and clostridial C2 toxin.

Authors:  Jörg Fahrer; Joschua Funk; Maren Lillich; Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-07       Impact factor: 3.000

3.  A New Versatile Immobilization Tag Based on the Ultra High Affinity and Reversibility of the Calmodulin-Calmodulin Binding Peptide Interaction.

Authors:  Somnath Mukherjee; Marcin Ura; Robert J Hoey; Anthony A Kossiakoff
Journal:  J Mol Biol       Date:  2015-07-06       Impact factor: 5.469

4.  Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo.

Authors:  Philippe Valadon; Bryan Darsow; Tim N Buss; Malgorzata Czarny; Noelle M Griffin; Han N Nguyen; Phil Oh; Per Borgstrom; Adrian Chrastina; Jan E Schnitzer
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

5.  Hierarchical functional gradients of pH-responsive self-assembled monolayers using dynamic covalent chemistry on surfaces.

Authors:  Lara Tauk; André P Schröder; Gero Decher; Nicolas Giuseppone
Journal:  Nat Chem       Date:  2009-10-23       Impact factor: 24.427

6.  Comparison of Förster-resonance-energy-transfer acceptors for tryptophan and tyrosine residues in native proteins as donors.

Authors:  Yi zhang; Xiaolan Yang; Lin Liu; Xuexia Huang; Zuexia Huang; Jun Pu; Gaobo Long; Ling Zhang; Dong Liu; Bangtian Xu; Juan Liao; Fei Liao
Journal:  J Fluoresc       Date:  2012-09-22       Impact factor: 2.217

7.  The structure of the SBP-Tag-streptavidin complex reveals a novel helical scaffold bridging binding pockets on separate subunits.

Authors:  Isabelle H Barrette-Ng; Sau Ching Wu; Wai Mui Tjia; Sui Lam Wong; Kenneth K S Ng
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-04-19

Review 8.  Functionalized amphipols: a versatile toolbox suitable for applications of membrane proteins in synthetic biology.

Authors:  Eduardo Antonio Della Pia; Randi Westh Hansen; Manuela Zoonens; Karen L Martinez
Journal:  J Membr Biol       Date:  2014-04-13       Impact factor: 1.843

9.  High-throughput biotinylation of proteins.

Authors:  Brian K Kay; Sang Thai; Veronica V Volgina
Journal:  Methods Mol Biol       Date:  2009

10.  A potential targeting gene vector based on biotinylated polyethyleneimine/avidin bioconjugates.

Authors:  Xuan Zeng; Yun-Xia Sun; Xian-Zheng Zhang; Si-Xue Cheng; Ren-Xi Zhuo
Journal:  Pharm Res       Date:  2009-06-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.